MP470
Term · Oncology and biomedicine · MLC-T-ONC-005520
A substance being studied in the treatment of some types of cancer. It may block certain proteins involved in cancer cell growth and DNA repair. Blocking these proteins may make cancer cells more sensitive to anticancer drugs and radiation therapy. MP470 is a type of tyrosine kinase inhibitor. Also called amuvatinib.
| Identifier | MLC-T-ONC-005520 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | amuvatinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005520",
"term": "MP470",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It may block certain proteins involved in cancer cell growth and DNA repair. Blocking these proteins may make cancer cells more sensitive to anticancer drugs and radiation therapy. MP470 is a type of tyrosine kinase inhibitor. Also called amuvatinib.",
"expansions": [
"amuvatinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mp470/"
}
Record 11,308 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.